Stay updated on Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Sign up to get notified when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the Record History page, indicating a routine site release rather than a content change to the study record.
    Difference
    0.1%
    Check dated 2026-05-14T23:07:15.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.5.2 to v3.5.3, signaling a new site build rather than a modification to the study record.
    Difference
    0.1%
    Check dated 2026-04-30T16:46:30.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 has been added to the record history, replacing the older v3.5.0 entry.
    Difference
    0.1%
    Check dated 2026-04-16T10:35:38.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    Revision history updated to add v3.5.0 and remove v3.4.3 from the record history. This is an administrative update to the record-keeping and does not change the study content.
    Difference
    0.1%
    Check dated 2026-03-25T20:55:15.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    Version 3.4.3 adds Contacts/Locations, Study Design, Study Status, and Recruitment Status. It also updates the recruitment status to Active, not recruiting on 2026-03-05, replacing the previous Recruiting status.
    Difference
    1%
    Check dated 2026-03-11T17:11:37.000Z thumbnail image
  8. Check
    96 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added to the Record History; removed a government funding lapse notice and Revision: v3.4.1.
    Difference
    0.9%
    Check dated 2026-02-11T02:17:41.000Z thumbnail image

Stay in the know with updates to Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Daratumumab in Myeloma: First Line & Re-treatment Clinical Trial page.